Design of lipid nanoparticle delivery agents for multivalent display of recombinant Env trimers in HIV vaccination
Name
Pejawar-Gaddy-2012-Design of lipid nano.pdf
Size
127.62 KB
Format
Adobe PDF
Checksum (MD5)
c1092c4d2d97511813a17fec1725745c
Author(s)
Pejawar Gaddy, Sharmila
Kovacs, J.
Barouch, D.
Chen, B.
Irvine, Darrell J.
Date Issued
September 2012
Journal
Retrovirology
Publisher
BioMed Central Ltd.
Citation
Pejawar-Gaddy, S et al. “Design of Lipid Nanoparticle Delivery Agents for Multivalent Display of Recombinant Env Trimers in HIV Vaccination.” Retrovirology 9.Suppl 2 (2012): O10.
Version
Final published version
Abstract
Background:
Immunization strategies that elicit antibodies capable of neutralizing diverse strains of the virus will likely be an important part of a successful vaccine against HIV. The envelope trimer is the only neutralizing target on the virus, and strategies to promote durable, high avidity antibody responses against the native intact trimer structure are lacking. We recently developed chemically-crosslinked lipid nanocapsules as carriers of molecular adjuvants and encapsulated or surface-displayed antigens, which promote follicular helper T-cell responses and elicited high-avidity, durable antibody responses to a candidate malaria antigen (Moon et al. Nat. Mater. 10 243 (2011); Moon et al. PNAS 109 1080 (2012)).
Methods:
To apply this system to the delivery of HIV antigens, we developed a strategy to anchor recombinant envelope trimers to the surfaces of these particles under conditions preserving the antigenic integrity of the trimers, allowing multivalent display of these immunogens for immunization. To anchor trimers in their native orientation, gp140 trimers with terminal his-tags were anchored to the surface of lipid nanocapsules via Ni-NTA-functionalized lipids.
Results:
Owing to their significant size (409 kDa) and heavy glycosylation, we found that liquid-ordered and/or gel-phase lipid compositions were required to stably anchor trimers to particle membranes. Trimer-loaded nanocapsules carrying monophosphoryl lipid A elicited durable antibody responses with titers comparable to a Complete Freund’s Adjuvant (CFA)-like emulsion in mice, without the toxic inflammation associated with the latter adjuvant. Further, nanocapsules elicited strong helper T-cell responses associated with a steadily increasing avidity of trimer-binding antibody over 90 days, which was not replicated by other adjuvants.
Conclusion:
These results suggest that nanoparticles displaying HIV trimers in an oriented, multivalent presentation can promote key aspects of the humoral response against Env immunogens.
MIT Department
Massachusetts Institute of Technology. Department of Materials Science and Engineering
Terms of Use
Creative Commons Attribution
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1186/1742-4690-9-s2-o10
